Remicade® (infliximab)
Authorization forms
Remicade is not covered for Traditional, Optimized or Medicaid
July 1 change: Remicade® infusions no longer covered
All existing approvals for Remicade (J1745) will be given a June 30, 2018 end date.
For further information, please see the Injectable drugs page.
Code(s): J1745
Benefit: Medical
Notes: Per 10 mg; for treatment of rheumatoid arthritis, ankylosing spondylosis, Crohn’s disease, ulcerative colitis, plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis